Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 203

1.

Serotonin Syndrome in an Adolescent Girl.

Mendelsohn J, Coffey BJ.

J Child Adolesc Psychopharmacol. 2019 Dec;29(10):783-786. doi: 10.1089/cap.2019.29175.bjc. No abstract available.

PMID:
31804878
2.

Nivolumab Is Effective in Mismatch Repair-Deficient Noncolorectal Cancers: Results From Arm Z1D-A Subprotocol of the NCI-MATCH (EAY131) Study.

Azad NS, Gray RJ, Overman MJ, Schoenfeld JD, Mitchell EP, Zwiebel JA, Sharon E, Streicher H, Li S, McShane LM, Rubinstein L, Patton DR, Williams PM, Coffey B, Hamilton SR, Bahary N, Suga JM, Hatoum H, Abrams JS, Conley BA, Arteaga CL, Harris L, O'Dwyer PJ, Chen AP, Flaherty KT.

J Clin Oncol. 2019 Nov 25:JCO1900818. doi: 10.1200/JCO.19.00818. [Epub ahead of print]

PMID:
31765263
3.

Prolonged acidosis is a feature of SGLT2i-induced euglycaemic diabetic ketoacidosis.

Rafey MF, Butt A, Coffey B, Reddington L, Devitt A, Lappin D, Finucane FM.

Endocrinol Diabetes Metab Case Rep. 2019 Sep 27;2019. pii: EDM190087. doi: 10.1530/EDM-19-0087. [Epub ahead of print]

4.

Amantadine for Treatment of Disruptive Mood Dysregulation Disorder Symptoms.

Rice T, Simon H, Barckak D, Maiyuran H, Chan V, Hassan Y, Tatum J, Coffey BJ.

J Child Adolesc Psychopharmacol. 2019 Oct;29(8):642-646. doi: 10.1089/cap.2019.29172.bjc. No abstract available. Erratum in: J Child Adolesc Psychopharmacol. 2019 Dec;29(10):790.

PMID:
31592724
5.

Metopic Craniosynostosis, Paroxysmal Dyskinesias, and Conversion Disorder (Psychogenic Nonepileptic Seizures) in an Early Adolescent with Depression: Challenges of Diagnosis and Treatment.

Yang GJ, Buneviciute J, Rice T, Coffey BJ.

J Child Adolesc Psychopharmacol. 2019 Aug;29(6):466-471. doi: 10.1089/cap.2019.29170.bjc. No abstract available.

PMID:
31348714
6.

Brief Psychosis in the Premenstrual Phase in an Adolescent Girl: Adolescent Menstrual Psychosis?

Langer S, Frankel J, Derish N, Poulsen R, Coffey BJ.

J Child Adolesc Psychopharmacol. 2019 Jun;29(5):392-394. doi: 10.1089/cap.2019.29168.bjc. No abstract available.

PMID:
31166800
7.

Complexity in Evaluation and Pharmacological Treatment of Early Onset Psychosis with Mood Symptoms: Childhood Onset Schizophrenia or Affective Disorder?

Jerath AU, Mavrides NA, Coffey BJ.

J Child Adolesc Psychopharmacol. 2019 Apr;29(3):241-244. doi: 10.1089/cap.2019.29164.bjc. No abstract available.

PMID:
30946619
8.

New-Onset Psychosis in a Child with Suspected Kleine-Levin Syndrome.

Rice T, Tatum J, Juneja N, Coffey BJ.

J Child Adolesc Psychopharmacol. 2019 Mar;29(2):158-161. doi: 10.1089/cap.2019.29161.bjc. No abstract available.

PMID:
30843731
9.

Interrogating the Genetic Determinants of Tourette's Syndrome and Other Tic Disorders Through Genome-Wide Association Studies.

Yu D, Sul JH, Tsetsos F, Nawaz MS, Huang AY, Zelaya I, Illmann C, Osiecki L, Darrow SM, Hirschtritt ME, Greenberg E, Muller-Vahl KR, Stuhrmann M, Dion Y, Rouleau G, Aschauer H, Stamenkovic M, Schlögelhofer M, Sandor P, Barr CL, Grados M, Singer HS, Nöthen MM, Hebebrand J, Hinney A, King RA, Fernandez TV, Barta C, Tarnok Z, Nagy P, Depienne C, Worbe Y, Hartmann A, Budman CL, Rizzo R, Lyon GJ, McMahon WM, Batterson JR, Cath DC, Malaty IA, Okun MS, Berlin C, Woods DW, Lee PC, Jankovic J, Robertson MM, Gilbert DL, Brown LW, Coffey BJ, Dietrich A, Hoekstra PJ, Kuperman S, Zinner SH, Luðvigsson P, Sæmundsen E, Thorarensen Ó, Atzmon G, Barzilai N, Wagner M, Moessner R, Ophoff R, Pato CN, Pato MT, Knowles JA, Roffman JL, Smoller JW, Buckner RL, Willsey AJ, Tischfield JA, Heiman GA, Stefansson H, Stefansson K, Posthuma D, Cox NJ, Pauls DL, Freimer NB, Neale BM, Davis LK, Paschou P, Coppola G, Mathews CA, Scharf JM; Tourette Association of America International Consortium for Genetics, the Gilles de la Tourette GWAS Replication Initiative, the Tourette International Collaborative Genetics Study, and the Psychiatric Genomics Consortium Tourette Syndrome Working Group.

Am J Psychiatry. 2019 Mar 1;176(3):217-227. doi: 10.1176/appi.ajp.2018.18070857.

PMID:
30818990
10.

Optimizing Clozapine Benefit While Minimizing Adverse Effects with Concomitant Fluvoxamine Treatment in an Adolescent with Schizoaffective Disorder.

Rice T, Friedman S, Tatum J, Weiss-Goldman N, Kufert Y, Coffey BJ.

J Child Adolesc Psychopharmacol. 2019 Feb;29(1):66-71. doi: 10.1089/cap.2018.29159.bjc. No abstract available.

PMID:
30681385
11.

Multidisciplinary Management of Adolescent Early-Onset, Treatment-Resistant Schizophrenia Complicated by Avoidant/Restrictive Food Intake Disorder and Catatonia in Acute Exacerbations.

Westfall NC, Mavrides NA, Coffey BJ.

J Child Adolesc Psychopharmacol. 2018 Nov;28(9):663-666. doi: 10.1089/cap.2018.29157.bjc. Epub 2018 Nov 14. No abstract available.

PMID:
30427723
12.

Guanfacine as a Facilitator of Recovery from Conversion Disorder in a Young Girl.

Rice T, Grasso J, Dembar A, Caplan O, Cohen A, Coffey B.

J Child Adolesc Psychopharmacol. 2018 Oct;28(8):571-575. doi: 10.1089/cap.2018.29154.bjc. No abstract available.

PMID:
30307762
13.

A cross-species approach to disorders affecting brain and behaviour.

Devinsky O, Boesch JM, Cerda-Gonzalez S, Coffey B, Davis K, Friedman D, Hainline B, Houpt K, Lieberman D, Perry P, Prüss H, Samuels MA, Small GW, Volk H, Summerfield A, Vite C, Wisniewski T, Natterson-Horowitz B.

Nat Rev Neurol. 2018 Nov;14(11):677-686. doi: 10.1038/s41582-018-0074-z. Review.

14.

Fourteen-Pound Fluvoxamine-Associated Weight Gain in a Young Woman with Depression and Multiple Anxiety Symptoms.

Jaffe RJ, Juneja NS, Juneja NS, Jaffe RJ, Coffey BJ.

J Child Adolesc Psychopharmacol. 2018 Sep;28(7):488-490. doi: 10.1089/cap.2018.29152.bjc. No abstract available.

PMID:
30226805
15.

High-dose ondansetron reduces activation of interoceptive and sensorimotor brain regions.

Stern ER, Shahab R, Grimaldi SJ, Leibu E, Murrough JW, Fleysher L, Parides MK, Coffey BJ, Burdick KE, Goodman WK.

Neuropsychopharmacology. 2019 Jan;44(2):390-398. doi: 10.1038/s41386-018-0174-x. Epub 2018 Aug 8.

PMID:
30116006
16.

A guide to policy analysis as a research method.

Browne J, Coffey B, Cook K, Meiklejohn S, Palermo C.

Health Promot Int. 2019 Oct 1;34(5):1032-1044. doi: 10.1093/heapro/day052.

PMID:
30101276
17.

Activation in Children and Adolescents Treated With Selective Serotonin Reuptake Inhibitors: A Weighty Reason?

Garcia-Delgar B, Morer A, Varela E, Romero S, García M, Coffey BJ, Lázaro L.

J Clin Psychopharmacol. 2018 Oct;38(5):475-480. doi: 10.1097/JCP.0000000000000923.

PMID:
30063503
18.

Psychopharmacology of the Rage Attack Phenomenon in a Child with Obsessive Compulsive Disorder.

Weiss-Goldman N, Arditi B, Rice T, Coffey BJ.

J Child Adolesc Psychopharmacol. 2018 Jun;28(5):360-362. doi: 10.1089/cap.2018.29150.bjc. No abstract available.

PMID:
29889566
19.

Medication Reconciliation: Making Bupropion Work After a "Bad Experience".

Westfall NC, Coffey BJ.

J Child Adolesc Psychopharmacol. 2018 Apr;28(3):238-242. doi: 10.1089/cap.2018.29147.bjc. No abstract available.

PMID:
29641251
20.

Medication Nonadherence Secondary to Choking Phobia (Phagophobia) in an Adolescent with Significant Trauma History: Addressing the Issue of Mental Contamination.

Kim Y, Kim J, Cohen A, Backus M, Arnovitz M, Rice T, Luber MJ, Coffey BJ.

J Child Adolesc Psychopharmacol. 2017 Sep;27(7):667-672. No abstract available.

PMID:
28930500
21.

Impulsive Aggressive Behavior Triggered by Headaches in a Child with Severe Attention-Deficit/Hyperactivity Disorder.

Yang TC, Luber MJ, Coffey BJ.

J Child Adolesc Psychopharmacol. 2017 Aug;27(6):555-558. doi: 10.1089/cap.2017.29137.bjc. No abstract available.

PMID:
28820639
22.

Extended-Release Guanfacine Does Not Show a Large Effect on Tic Severity in Children with Chronic Tic Disorders.

Murphy TK, Fernandez TV, Coffey BJ, Rahman O, Gavaletz A, Hanks CE, Tillberg CS, Gomez LI, Sukhodolsky DG, Katsovich L, Scahill L.

J Child Adolesc Psychopharmacol. 2017 Nov;27(9):762-770. doi: 10.1089/cap.2017.0024. Epub 2017 Jul 19.

PMID:
28723227
23.

Paradoxical Hypertensive Urgency in a Child After Initiation of Guanfacine.

Luber MJ, Coffey BJ, Gamms SH.

J Child Adolesc Psychopharmacol. 2017 Jun;27(5):466-468. doi: 10.1089/cap.2017.29134.bjc. No abstract available.

PMID:
28613939
24.

Investigation of previously implicated genetic variants in chronic tic disorders: a transmission disequilibrium test approach.

Abdulkadir M, Londono D, Gordon D, Fernandez TV, Brown LW, Cheon KA, Coffey BJ, Elzerman L, Fremer C, Fründt O, Garcia-Delgar B, Gilbert DL, Grice DE, Hedderly T, Heyman I, Hong HJ, Huyser C, Ibanez-Gomez L, Jakubovski E, Kim YK, Kim YS, Koh YJ, Kook S, Kuperman S, Leventhal B, Ludolph AG, Madruga-Garrido M, Maras A, Mir P, Morer A, Müller-Vahl K, Münchau A, Murphy TL, Plessen KJ, Roessner V, Shin EY, Song DH, Song J, Tübing J, van den Ban E, Visscher F, Wanderer S, Woods M, Zinner SH, King RA, Tischfield JA, Heiman GA, Hoekstra PJ, Dietrich A.

Eur Arch Psychiatry Clin Neurosci. 2018 Apr;268(3):301-316. doi: 10.1007/s00406-017-0808-8. Epub 2017 May 29.

25.

Treatment of Hallucinations in the Context of Anxiety: When Less Is More.

Thom RP, Hall W, Maneta E, Luber MJ, Coffey BJ.

J Child Adolesc Psychopharmacol. 2017 May;27(4):389-392. doi: 10.1089/cap.2017.29133.bjc. No abstract available.

PMID:
28489429
26.

Lithium and Heart Block in an Adolescent Boy.

Rice PT, Kufert Y, Luber MJ, Coffey BJ.

J Child Adolesc Psychopharmacol. 2017 Apr;27(3):285-288. doi: 10.1089/cap.2017.29130.bjc. No abstract available.

PMID:
28414533
27.

Persistent Tics, Tourette Syndrome, and Psychopathology: Where Are We Now, and Where Are We Going?

Coffey BJ.

J Am Acad Child Adolesc Psychiatry. 2017 Apr;56(4):281-283. doi: 10.1016/j.jaac.2017.01.015. No abstract available.

PMID:
28335870
28.

Clozapine-Related Tachycardia in an Adolescent with Treatment-Resistant Early Onset Schizophrenia.

Kolli V, Bourke D, Ngo J, Luber MJ, Coffey BJ.

J Child Adolesc Psychopharmacol. 2017 Mar;27(2):206-208. doi: 10.1089/cap.2017.29123.bjc. No abstract available.

PMID:
28323458
29.

Challenges in the Psychopharmacological Management of Very Early-Onset Schizophrenia and Anxiety.

Mehdi A, Schweinsburg BC, Zehgeer A, Connor DF, Luber MJ, Coffey BJ.

J Child Adolesc Psychopharmacol. 2016 Dec;26(10):944-947. No abstract available.

30.

Deutetrabenazine in Tics Associated with Tourette Syndrome.

Jankovic J, Jimenez-Shahed J, Budman C, Coffey B, Murphy T, Shprecher D, Stamler D.

Tremor Other Hyperkinet Mov (N Y). 2016 Nov 7;6:422. eCollection 2016.

31.

Obsessive-Compulsive Disorder, Tics, and Autoinflammatory Diseases: Beyond PANDAS.

Garcia-Delgar B, Morer A, Luber MJ, Coffey BJ.

J Child Adolesc Psychopharmacol. 2016 Nov;26(9):847-850. No abstract available.

32.

Decreased Anterior Cingulate Cortex γ-Aminobutyric Acid in Youth With Tourette's Disorder.

Freed RD, Coffey BJ, Mao X, Weiduschat N, Kang G, Shungu DC, Gabbay V.

Pediatr Neurol. 2016 Dec;65:64-70. doi: 10.1016/j.pediatrneurol.2016.08.017. Epub 2016 Sep 12.

PMID:
27743746
33.

Autoimmune Thyroiditis in an Adolescent Girl on Lithium.

Pesavento JA, Kolli V, Garcia-Delgar B, Coffey BJ.

J Child Adolesc Psychopharmacol. 2016 Oct;26(8):756-759. No abstract available.

34.

Psychopharmacotherapy of Severe Self-injury in an Adolescent with Gender Dysphoria and Comorbidity.

Rice T, Kufert Y, Walther A, Feldman E, Garcia-Delgar B, Coffey BJ.

J Child Adolesc Psychopharmacol. 2016 Sep;26(7):646-50. doi: 10.1089/cap.2016.29114.bjc. No abstract available.

PMID:
27642794
35.

Pre- and perinatal complications in relation to Tourette syndrome and co-occurring obsessive-compulsive disorder and attention-deficit/hyperactivity disorder.

Abdulkadir M, Tischfield JA, King RA, Fernandez TV, Brown LW, Cheon KA, Coffey BJ, de Bruijn SF, Elzerman L, Garcia-Delgar B, Gilbert DL, Grice DE, Hagstrøm J, Hedderly T, Heyman I, Hong HJ, Huyser C, Ibanez-Gomez L, Kim YK, Kim YS, Koh YJ, Kook S, Kuperman S, Lamerz A, Leventhal B, Ludolph AG, Madruga-Garrido M, Maras A, Messchendorp MD, Mir P, Morer A, Münchau A, Murphy TL, Openneer TJ, Plessen KJ, Rath JJ, Roessner V, Fründt O, Shin EY, Sival DA, Song DH, Song J, Stolte AM, Tübing J, van den Ban E, Visscher F, Wanderer S, Woods M, Zinner SH, State MW, Heiman GA, Hoekstra PJ, Dietrich A.

J Psychiatr Res. 2016 Nov;82:126-35. doi: 10.1016/j.jpsychires.2016.07.017. Epub 2016 Jul 22.

36.

Polycystic Ovary Syndrome and Obsessive-Compulsive Disorder: Interactions and Psychopharmacological Considerations.

Rice T, Barcak D, Garcia-Delgar B, Coffey BJ.

J Child Adolesc Psychopharmacol. 2016 Aug;26(6):562-5. doi: 10.1089/cap.2016.29111.bjc. Epub 2016 Aug 3. No abstract available.

PMID:
27487421
37.

Psychopharmacologic Management of Anxiety in an Adolescent with Congenital Long QT Syndrome.

Minton TB, Rosing J, Spar DS, Strawn JR, Garcia-Delgar B, Coffey BJ.

J Child Adolesc Psychopharmacol. 2016 Jun;26(5):485-9. doi: 10.1089/cap.2016.29109.bjc. Epub 2016 Jun 10. No abstract available.

38.

New-Onset Psychosis in an Adolescent with Wilson's Disease.

Azova S, Rice T, Garcia-Delgar B, Coffey BJ.

J Child Adolesc Psychopharmacol. 2016 Apr;26(3):301-4. doi: 10.1089/cap.2016.29106.bjc. No abstract available.

PMID:
27097017
39.

Quetiapine Addiction in an Adolescent.

Kolli V, Mary H, Garcia-Delgar B, Coffey BJ.

J Child Adolesc Psychopharmacol. 2016 Mar;26(2):174-6. doi: 10.1089/cap.2016.29104.bjc. No abstract available.

PMID:
27007452
40.

Staying Up at Night: Overlapping Bipolar and Obsessive-Compulsive Disorder Symptoms in an Adolescent with Autism Spectrum Disorder.

Cawkwell P, Lawler A, Maneta E, Coffey BJ.

J Child Adolesc Psychopharmacol. 2016 Feb;26(1):74-7. doi: 10.1089/cap.2016.29100.bjc. No abstract available.

PMID:
26881860
41.

Evaluating the ability of novices to identify and quantify physical demand elements following an introductory education session: A pilot study.

Coffey B, VanderGriendt C, Fischer SL.

Appl Ergon. 2016 May;54:33-40. doi: 10.1016/j.apergo.2015.11.021. Epub 2015 Dec 14.

PMID:
26851462
42.

The Impact of Psychosocial Stressors on Treatment of a Teenage Girl with Obsessive Compulsive Disorder, Trichotillomania, and Anxiety.

Phan TD, Kostek NT, Coffey BJ.

J Child Adolesc Psychopharmacol. 2015 Nov;25(9):722-5. doi: 10.1089/cap.2015.29035.bjc. No abstract available.

PMID:
26579630
43.

Negative Symptoms in a Depressed Teen? Primary Hyperparathyroidism and its Psychiatric Manifestations.

Rice T, Azova S, Coffey BJ.

J Child Adolesc Psychopharmacol. 2015 Oct;25(8):653-5. doi: 10.1089/cap.2015.29028.bjc. No abstract available.

PMID:
26485087
44.

Metformin in an Adolescent with Significant Weight Gain.

Salau M, Adam B, Coffey BJ.

J Child Adolesc Psychopharmacol. 2015 Sep;25(7):589-92. doi: 10.1089/cap.2015.29022.bjc. No abstract available.

PMID:
26375769
45.

Posttraumatic Stress Disorder in a Child with Autism Spectrum Disorder: Challenges in Management.

Trelles Thorne Mdel P, Khinda N, Coffey BJ.

J Child Adolesc Psychopharmacol. 2015 Aug;25(6):514-7. doi: 10.1089/cap.2015.29011.mptt. No abstract available.

PMID:
26262906
46.

Pharmacotherapeutic Considerations in the Treatment of an Adolescent with Anorexia Nervosa and Obsessive Compulsive Disorder.

Rice T, Coffey BJ.

J Child Adolesc Psychopharmacol. 2015 Jun;25(5):444-7. doi: 10.1089/cap.2015.29006.bjc. No abstract available.

47.

Neuroleptic Malignant Syndrome in a Boy with NMDA Receptor Encephalitis.

Berg A, Byrne R, Coffey BJ.

J Child Adolesc Psychopharmacol. 2015 May;25(4):368-71. doi: 10.1089/cap.2015.29000.bjc. No abstract available.

PMID:
25978744
48.

Callous-unemotional traits in a child with attention-deficit/hyperactivity disorder and oppositional defiant disorder: managing medication and expectations.

Shah LD, Coffey BJ.

J Child Adolesc Psychopharmacol. 2015 Apr;25(3):272-5. doi: 10.1089/cap.2015.2533. No abstract available.

PMID:
25885014
49.

Relationship Between Vertebral Fracture Burden, Height Loss, and Pulmonary Function in Postmenopausal Women With Osteoporosis.

Krege JH, Kendler D, Krohn K, Genant H, Alam J, Berclaz PY, Coffey B, Loghin C.

J Clin Densitom. 2015 Oct-Dec;18(4):506-11. doi: 10.1016/j.jocd.2015.02.004. Epub 2015 Mar 29.

50.

Pharmacotherapeutic challenges in treatment of a child with "the triad" of obsessive compulsive disorder, attention-deficit/hyperactivity disorder and Tourette's disorder.

Rice T, Coffey B.

J Child Adolesc Psychopharmacol. 2015 Mar;25(2):176-9. doi: 10.1089/cap.2015.2522. No abstract available.

PMID:
25782100

Supplemental Content

Loading ...
Support Center